Rankings
▼
Calendar
XENE Q3 2021 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
XENE
Xenon Pharmaceuticals Inc.
$5B
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
+24.0% YoY
Gross Profit
-$11M
-132.5% margin
Operating Income
-$16M
-192.0% margin
Net Income
-$15M
-190.1% margin
EPS (Diluted)
$-0.37
QoQ Revenue Growth
+266.3%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$15M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$264M
Total Liabilities
$15M
Stockholders' Equity
$249M
Cash & Equivalents
$88M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$7M
+24.0%
Gross Profit
-$11M
$7M
-264.3%
Operating Income
-$16M
-$10M
-60.8%
Net Income
-$15M
-$9M
-74.4%
Revenue Segments
License And Service
$3M
100%
← FY 2021
All Quarters
Q4 2021 →